There are a number of products on the market which make unsubstantiated or misleading claims about the power of AI in its use for skin cancer triage and diagnostics. Moreover, AI app developers are seemingly unaware of the relevant regulatory1 and ethics2 governance frameworks for the usage of their products.
These principle areas are summarised in a Position Statement. The WPG are also working to develop a regulatory framework to support commissioners / buyers of AI technologies specifically in Dermatology.
Additionally, please follow this link to view a flowchart to determine if an AI tool is appropriate for clinical deployment
The Health Research Authority HRA) have best practice guidance for informing participants and seeking consent, including an online tool giving guidance on consent and preparation of information for participants and other resources.